White Paper
Post COVID-19 reboot of clinical trials in Asia Pacific
Jul 09, 2020
The recent restrictions imposed by many countries in response to the recent COVID-19 outbreak has impacted ongoing clinical research, and restarting clinical trials is a critically important activity. IQVIA investigates how research sites are utilizing a variety of measures, including diagnostic tests, in an attempt to minimize risk of external transmission of the infection to staff and patients at the site.